Zynyz
Payments companies reported to CMS as associated with Zynyz. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zynyz, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zynyz
These are the largest totals companies reported as associated with Zynyz. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Morse | Durham, NC | Hematology & Oncology | $80,431.28 |
| Midhun Malla | Birmingham, AL | Hematology & Oncology | $71,713.19 |
| Mohamad Khair Khasawneh | Maywood, IL | Hematology & Oncology | $57,505.52 |
| Amit Mahipal | Rochester, MN | Medical Oncology | $47,643.70 |
| Mohammed Al Hallak | Detroit, MI | Hematology & Oncology | $44,127.87 |
| Joshua Strauss | Springfield, NJ | Hematology & Oncology | $40,347.91 |
| Boris Naraev | Tampa, FL | Medical Oncology | $39,233.11 |
| Erin Schwab | Dillon, CO | Hematology & Oncology | $39,137.74 |
| Jennifer Valerin | Orange, CA | Medical Oncology | $29,172.75 |
| Ronan Hsieh | Seattle, WA | Hematology & Oncology | $27,894.21 |
Prescribed Zynyz?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.